WGS
GeneDx Holdings Corp.
$151.51
-$3.86(-2.48%)
48
Overall
20
Value
66
Tech
60
Quality
Market Cap
$4.15B
Volume
510.41K
52W Range
$55.17 - $170.87
Target Price
$157.88
Company Overview
| Mkt Cap | $4.15B | Price | $151.51 |
| Volume | 510.41K | Change | -2.48% |
| P/E Ratio | -79.3 | Open | $157.15 |
| Revenue | $305.4M | Prev Close | $155.37 |
| Net Income | $-52.3M | 52W Range | $55.17 - $170.87 |
| Div Yield | N/A | Target | $157.88 |
| Overall | 48 | Value | 20 |
| Quality | 60 | Technical | 66 |
No chart data available
About GeneDx Holdings Corp.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company is headquartered in Stamford, Connecticut.
Latest News
BTIG Keeps Their Buy Rating on GeneDx Holdings (WGS)
TipRanks Auto-Generated Intelligence Newsdesk•2 days ago
Why Cathie Wood Dumps Two ‘Magnificent 7’ Stocks — and Makes a Bold Bet on Trade Desk (TTD) Instead
Shalu Saraf•9 days ago
Piper Sandler Remains a Buy on GeneDx Holdings (WGS)
TipRanks Auto-Generated Intelligence Newsdesk•10 days ago
WGS, WRD, IRDM: Cathie Wood Ramps Up Buying in GeneDx and WeRide, Trims Exposure in Iridium stock
Shalu Saraf•10 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | WGS | $151.51 | -2.5% | 510.41K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |